iCanWork Intervention for Malignant Neoplasms

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
McGill University, Montréal, Canada
Malignant Neoplasms+2 More
iCanWork Intervention - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

The aim of this study is to evaluate the effectiveness of the iCanWork intervention in assisting cancer survivors (CS) to return to work (RTW) and its impact on their health-related quality of life (QoL), health service utilization, RTW readiness, time to RTW, and work capacity.

Eligible Conditions

  • Quality of Life (QOL)
  • Malignant Neoplasms
  • Survival Rate (Survivorship)

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: baseline, 6 months, 12 months, 18 months, 24 months

Month 24
Change from baseline health related quality of life in the course of the 24-month study
Change from baseline readiness to return to work in the course of the 24-month study
Change from baseline return to work status in the course of the 24-month study
Change from baseline work capacity in the course of the 24-month study

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Control
1 of 2
iCanWork Intervention
1 of 2
Active Control
Experimental Treatment

270 Total Participants · 2 Treatment Groups

Primary Treatment: iCanWork Intervention · No Placebo Group · N/A

iCanWork Intervention
Behavioral
Experimental Group · 1 Intervention: iCanWork Intervention · Intervention Types: Behavioral
ControlNoIntervention Group · 1 Intervention: Control · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, 6 months, 12 months, 18 months, 24 months
Closest Location: McGill University · Montréal, Canada
Photo of quebec 1Photo of quebec 2Photo of quebec 3
2018First Recorded Clinical Trial
0 TrialsResearching Malignant Neoplasms
130 CompletedClinical Trials

Who is running the clinical trial?

McGill UniversityLead Sponsor
348 Previous Clinical Trials
972,475 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 6 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are gainfully employed at the time of diagnosis.
You have not returned to work, due to cancer.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.